Association of Strabismus With Mood Disorders, Schizophrenia, and Anxiety Disorders Among Children.


Journal

JAMA ophthalmology
ISSN: 2168-6173
Titre abrégé: JAMA Ophthalmol
Pays: United States
ID NLM: 101589539

Informations de publication

Date de publication:
01 04 2022
Historique:
pubmed: 11 3 2022
medline: 26 4 2022
entrez: 10 3 2022
Statut: ppublish

Résumé

Children with strabismus have poorer functional vision and decreased quality of life than those without strabismus. To evaluate the association between strabismus and mental illness among children. This cross-sectional study analyzed claims data from the OptumLabs Data Warehouse, a longitudinal deidentified commercial insurance claims database, from 12 005 189 patients enrolled in the health plan between January 1, 2007, and December 31, 2017. Eligibility criteria included age younger than 19 years at the time of strabismus diagnosis, enrollment in the health plan between 2007 and 2018, and having at least 1 strabismus claim based on International Classification of Diseases, Ninth Revision, Clinical Modification and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Clinical Modification codes. Controls were children in the same database with no eye disease codes other than refractive error reported. Demographic characteristics and mental illness claims were compared. Statistical analysis was conducted from December 1, 2018, to July 31, 2021. Presence of mental illness claims. Among the 12 005 189 patients (6 095 523 boys [50.8%]; mean [SD] age, 8.0 [5.9] years) in the study, adjusted odds ratios for the association of mental illnesses with strabismus were 2.01 (95% CI, 1.99-2.04) for anxiety disorder, 1.83 (95% CI, 1.76-1.90) for schizophrenia, 1.64 (95% CI, 1.59-1.70) for bipolar disorder, 1.61 (95% CI, 1.59-1.63) for depressive disorder, and 0.99 (95% CI, 0.97-1.02) for substance use disorder. There was a moderate association between each strabismus type (esotropia, exotropia, and hypertropia) and anxiety disorder, schizophrenia, bipolar disorder, and depressive disorder; odds ratios ranged from 1.23 (95% CI, 1.17-1.29) for the association between esotropia and bipolar disorder to 2.70 (95% CI, 2.66-2.74) for the association between exotropia and anxiety disorder. This cross-sectional study suggests that there was a moderate association between strabismus and anxiety disorder, schizophrenia, bipolar disorder, and depressive disorder but not substance use disorder. Recognizing that these associations exist should encourage mental illness screening and treatment for patients with strabismus.

Identifiants

pubmed: 35266979
pii: 2789797
doi: 10.1001/jamaophthalmol.2022.0137
pmc: PMC8914883
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-381

Subventions

Organisme : NEI NIH HHS
ID : R21 EY029655
Pays : United States

Commentaires et corrections

Type : CommentIn

Auteurs

Yoon H Lee (YH)

Department of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles.

Michael X Repka (MX)

Department of Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Marcy F Borlik (MF)

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles.

Federico G Velez (FG)

Department of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles.
Department of Ophthalmology, Doheny Eye Institute, University of California, Los Angeles, Los Angeles.
Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.

Claudia Perez (C)

Department of Medicine Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles.

Fei Yu (F)

Department of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles.
Department of Biostatistics, University of California, Los Angeles Fielding School of Public Health, Los Angeles.

Anne L Coleman (AL)

Department of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles.
Department of Epidemiology, University of California, Los Angeles Fielding School of Public Health, Los Angeles.

Stacy L Pineles (SL)

Department of Ophthalmology, Stein Eye Institute, University of California, Los Angeles, Los Angeles.
OptumLabs, Eden Prairie, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH